A Form 4 filed on September 11, 2026 with the U.S. Securities and Exchange Commission discloses that Kian Fatt Chong, Executive Vice President of Global Operations at Seagate Technology Holdings plc (NASDAQ:STX), acquired ordinary shares through the vesting of restricted share units on September …
Director Frank Wicks filed a Form 4 with the SEC on September 11, 2026, reporting the acquisition of 236 shares of Cass Information Systems Inc common stock on September 10, 2026.
Director Vivian M. Vitale filed a Form 4 with the SEC on September 11, 2026, disclosing the grant of 7,000 restricted stock units and the vesting of 7,000 restricted stock units in NetScout Systems Inc. (NASDAQ:NTCT) on September 9 and September 10, 2026, respectively.
UniFirst Corporation filed a current report on September 11, 2026, disclosing the final departure of Executive Vice President and Chief Operating Officer Kelly Rooney and the execution of a Separation Agreement and General Release on that same date.
M Evo Global Acquisition Corp II filed a Form 8-K on September 11, 2026, reporting the resignation of Stephen M. Silver as Chief Executive Officer, Chairman of the Board, and director, and the appointment of Ashley Zumwalt-Forbes to those roles, all effective September 9, …
Artiva Biotherapeutics, Inc. filed a Form 8-K on September 11, 2026, reporting the voting results from its 2026 Annual Meeting of Stockholders held on September 8, 2026, including stockholder approval of an amendment to its 2024 Equity Incentive Plan.
Essex Property Trust, Inc. filed a Form 8-K on September 11, 2026, under Item 7.01 Regulation FD Disclosure, announcing that its President and CEO will participate in a roundtable at the 2026 Bank of America Global Real Estate Conference.
Celestica Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on September 11, 2026, disclosing the appointment of Todd Ankenmann as Chief Financial Officer and the transition of current CFO Mandeep Chawla to a newly created Group President, Global Markets role, …
LifeStance Health Group, Inc. filed a Form 8-K on September 11, 2026, disclosing the closing of an underwritten secondary offering of 22,250,000 shares of common stock sold entirely by selling stockholders, with the company simultaneously repurchasing 2,000,000 of those shares.
A Form 4 filed on September 11, 2026, reports that Sherrese M. Smith, a director of Gen Digital Inc. (NASDAQ:GEN), acquired two separate grants of restricted stock units on September 9, 2026, through annual non-employee director equity programs.